Clinical value of serum iPTH, ALP and serum markers levels in patients with secondary hyperparathyroidism receiving paricalcitol combined with cinacalcet
The combination of paricalcitol and cinacalcet was effective in reducing iPTH, calcium, phosphorus, and ALP and improving Hb and Alb levels in patients with secondary hyperparathyroidism on maintenance hemodialysis. This treatment approach offers significant benefits in managing SHPT.
Authors
- Lu XiaoZhen
- Fadong Chen (ORCID: https://orcid.org/0000-0003-3934-580X)
- Xue Zengqi
Institutions
- Wenzhou Medical University (CN)
- Ruian People's Hospital (CN)
Publication Details
- Journal
- Journal of Medical Biochemistry
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5937/jomb0-55510
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00